Company performance
Current Price
as of Jan 07, 2025$1.12
P/E Ratio
N/A
Market Cap
$98.19M
- IMUX
Description
Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis. The firm’s products include IMU-838, IMU-935, and IMU-856. The company is headquartered in New York, NY.
Metrics
Overview
- HQNew York, NY
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerIMUX
- Price$1.12+2.75%
Trading Information
- Market cap$98.19M
- Float96.98%
- Average Daily Volume (1m)891,898
- Average Daily Volume (3m)999,928
- EPS-$1.24
Company
- RevenueN/A
- Rev growth (1yr)N/A
- Net income-$24.37M
- Gross marginN/A
- EBITDA marginN/A
- EBITDA-$25.68M
- EV$108.93M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
- P/B2.38
Documents
SEC Filings
Earnings Calls
Factset Street Account